News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY
Eckert & Ziegler SE reports strong Q1 results with medical segment driving growth. Isotope Products show recovery potential. Company updates recommendation to BUY with €23 target price. For more details, visit NuWays AG's website -
-
-
-
-
-